bioRxiv · 10.1101/2020.02.18.955286
CasRx-mediated RNA targeting prevents choroidal neovascularization in a mouse model of age-related macular degeneration
Abstract
The smallest Cas13 family protein, CasRx, has a high cleavage activity and targeting specificity, offering attractive opportunity for therapeutic applications. Here we report that delivery of CasRx by adeno-associated virus via intravitreal injection could efficiently knockdown Vegfa transcripts and significantly reduce the area of laser-induced choroidal neovascularization in a mouse model of age-related macular degeneration. Thus, RNA-targeting CRISPR system could be used for in vivo gene therapy.
Source connections
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Zhou, C., Hu, X., Tang, C., Liu, W., Wang, S., Zhou, Y., Zhao, Q., Bo, Q., Shi, L., Sun, X., Zhou, H., Yang, H.. 2020-02-20. CasRx-mediated RNA targeting prevents choroidal neovascularization in a mouse model of age-related macular degeneration. https://doi.org/10.1101/2020.02.18.955286
Cite the original work for its findings. Save a collection to share your selection of sources.